How should Medtronic balance the cost-effectiveness of its insulin pumps against the inclusion of advanced features like continuous glucose monitoring?

Introduction

Balancing cost-effectiveness and advanced features in Medtronic's insulin pumps presents a critical trade-off. We must weigh the financial accessibility of these life-saving devices against the inclusion of cutting-edge technology like continuous glucose monitoring (CGM). This decision impacts patient care, market competitiveness, and Medtronic's bottom line.

I'll approach this analysis by:

1. Clarifying key aspects of the situation
2. Identifying the specific trade-off type
3. Understanding the product and its ecosystem
4. Formulating a hypothesis and potential impacts
5. Defining key metrics
6. Designing an experiment
7. Planning data analysis
8. Creating a decision framework
9. Providing recommendations and next steps

Step 1

Clarifying Questions (3 minutes)

• Context: I'm assuming Medtronic is facing pressure from both patients and healthcare providers to offer more affordable insulin pumps. Could you provide more context on the current market dynamics and competitive landscape?

Why it matters: Understanding the market pressures will help prioritize cost reduction vs. feature inclusion. Expected answer: Increasing competition from lower-cost alternatives is putting pressure on Medtronic's market share. Impact on approach: Would emphasize cost reduction strategies if market share is declining significantly.

• Business Context: Based on Medtronic's position as a leader in medical devices, I'm thinking advanced features might be crucial for maintaining premium pricing. How does the insulin pump line contribute to overall revenue, and what are the current margins?

Why it matters: Helps assess the financial impact of potential changes to the product line. Expected answer: Insulin pumps are a significant revenue driver with healthy margins. Impact on approach: Would lean towards maintaining advanced features if they're key to preserving margins.

• User Impact: Considering the diverse needs of diabetes patients, I'm curious about our user segments. Can you share insights on the breakdown between users who prioritize advanced features versus those more concerned with cost?

Why it matters: Allows us to tailor solutions to different user needs and preferences. Expected answer: A mix of tech-savvy users willing to pay for advanced features and cost-conscious users seeking basic functionality. Impact on approach: Would consider a tiered product strategy to address different user segments.

• Technical: Given the complexity of integrating CGM with insulin pumps, I'm wondering about the technical feasibility of modularizing these features. Is it possible to offer CGM as an optional add-on rather than a built-in feature?

Why it matters: Could provide a middle ground between cost-effectiveness and advanced features. Expected answer: Modularization is technically possible but may impact overall system reliability. Impact on approach: Would explore modular designs if technically feasible and reliable.

• Resource: Considering the potential for a product line revamp, I'm thinking about our R&D capacity. What resources do we have available for developing cost-effective alternatives or refining existing products?

Why it matters: Determines the scope of potential solutions based on available resources. Expected answer: Limited R&D resources due to multiple ongoing projects. Impact on approach: Would focus on high-impact, resource-efficient solutions.